Literature DB >> 31539503

Starving the Devourer: Cutting Cancer Off from Its Favorite Foods.

William P Katt1, Michael J Lukey1, Richard A Cerione2.   

Abstract

Increased consumption of glucose and glutamine are metabolic hallmarks of tumorigenesis. In this issue of Cell Chemical Biology, Reckzeh et al. (2019) describe the discovery of Glutor, a potent inhibitor of cellular glucose uptake. Combining Glutor with the glutaminase inhibitor CB-839 creates a metabolic crisis in cancer cells, synergistically impeding proliferation.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Year:  2019        PMID: 31539503     DOI: 10.1016/j.chembiol.2019.09.005

Source DB:  PubMed          Journal:  Cell Chem Biol        ISSN: 2451-9448            Impact factor:   8.116


  3 in total

1.  Identification and Characterization of IMD-0354 as a Glutamine Carrier Protein Inhibitor in Melanoma.

Authors:  Yongmei Feng; Gaurav Pathria; Susanne Heynen-Genel; Michael Jackson; Brian James; Jun Yin; David A Scott; Ze'ev A Ronai
Journal:  Mol Cancer Ther       Date:  2021-02-25       Impact factor: 6.009

2.  Reduced Oxidative Phosphorylation and Increased Glycolysis in Human Glaucoma Lamina Cribrosa Cells.

Authors:  Khalid Kamel; Colm J O'Brien; Alexander V Zhdanov; Dmitri B Papkovsky; Abbot F Clark; W Daniel Stamer; Mustapha Irnaten
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-11-02       Impact factor: 4.799

3.  Regulation of aerobic glycolysis to decelerate tumor proliferation by small molecule inhibitors targeting glucose transporters.

Authors:  Meng Gao; Jian Huang; Xin Jiang; Yafei Yuan; Huanhuan Pang; Shuchen Luo; Nan Wang; Chengbo Yao; Zuwan Lin; Debing Pu; Shuo Zhang; Pengcheng Sun; Zhuoyi Liu; Yu Xiao; Qian Wang; Zeping Hu; Hang Yin
Journal:  Protein Cell       Date:  2020-06       Impact factor: 14.870

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.